2 results
Approved WMOCompleted
To evaluate the safety and efficacy of abicipar (2 mg), compared to 0.5 mg ranibizumab in treatment-naïve patients with neovascular AMD.
Approved WMOCompleted
The aim of this study is to image and model patient specific ACL-deficient knees applying several developed methods, to determine the feasibility of PKTD and MRI based FE models in assessing knee laxity in ACL-deficient knees before and after…